India Globalization Capital, Inc.
(NYSE Amex Equities : IGC)

( )
IGC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.98%346.610.0%$6986.58m
BNTXBioNTech SE 3.61%340.210.0%$1241.84m
SNSSSunesis Pharmaceuticals, Inc. 2.95%10.830.7%$757.06m
NVAXNovavax, Inc. 1.89%182.7279.8%$653.58m
AMGNAmgen, Inc. -0.73%239.791.3%$495.02m
BIIBBiogen, Inc. 1.52%331.701.7%$445.63m
VRTXVertex Pharmaceuticals, Inc. -1.62%198.321.9%$417.46m
GILDGilead Sciences, Inc. 0.09%68.351.0%$404.13m
REGNRegeneron Pharmaceuticals, Inc. 0.44%577.132.7%$316.04m
ILMNIllumina, Inc. -0.56%492.993.5%$256.31m
NTLAIntellia Therapeutics, Inc. -3.72%136.572.3%$194.31m
CRSPCRISPR Therapeutics AG 1.09%122.340.6%$138.33m
SGENSeagen Inc. 0.55%154.245.8%$128.55m
EXASEXACT Sciences Corp. 0.52%108.4018.1%$125.92m
XBIOXenetic Biosciences, Inc. 9.58%4.460.0%$123.60m

Company Profile

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.